METHOD FOR PROLIFERATION OF PLURIPOTENT STEM CELLS

• US 20110117645A1
• Filed: 03/31/2009
• Published: 05/19/2011
• Est. Priority Date: 03/31/2008
• Status: Abandoned Application

• Current Assignee: Kyoto University, Oriental Yeast Company Limited (Nisshin Seifun Group Incorporated)
• Original Assignee: Kyoto University, Oriental Yeast Company Limited (Nisshin Seifun Group Incorporated)
• Inventors: Yasuda, Hisataka, Yamada, Munehiro, Miyazaki, Kaoru, Takahashi, Kazutoshi
• Application Number:
  US12/922,244
• Publication Number:
  US 20110117645A1
• Time in Patent Office: Days
• US Class Current: 435/366
• CPC Class Codes: C12N 2500/10 Metals; Metal chelators
• CPC Class Codes: C12N 2500/12 Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
• CPC Class Codes: C12N 2500/20 Transition metals
• CPC Class Codes: C12N 2500/25 Insulin-transferrin; Insulin-transferrin-selenium
• CPC Class Codes: C12N 2500/32 Amino acids
• CPC Class Codes: C12N 2500/98 Xeno-free medium and culture conditions
• CPC Class Codes: C12N 2533/52 Fibronectin; Laminin
• CPC Class Codes: C12N 5/0606 Pluripotent embryonic cells, e.g. embryonic stem cells [ES] embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696
• CPC Class Codes: C12N 5/0696 Artificially induced pluripotent stem cells, e.g. iPS

Abstract

For efficient proliferation of pluripotent stem cells in a system free from any animal-derived material such as feeder cells or serum, the present invention provides a method for proliferation of pluripotent stem cells, which comprises culturing the pluripotent stem cells in a medium free from both feeder cells and serum in a system containing laminin-5.

Claims

1. A method for proliferation of pluripotent stem cells, which comprises culturing the pluripotent stem cells in a medium free from both feeder cells and serum in a system containing laminin-5.

2. The method according to claim 1, wherein the pluripotent stem cells are induced pluripotent stem cells.

3. The method according to claim 1, wherein the induced pluripotent stem cells are human induced pluripotent stem cells.

4. The method according to claim 1, wherein the pluripotent stem cells are selected from the group consisting of embryonic stem cells, embryonic germ cells, and germline stem cells.

5. The method according to claim 4, wherein the pluripotent stem cells are embryonic stem cells.

6. The method according to claim 1, wherein the culture medium comprises a serum replacement.

7. The method according to claim 6, wherein the serum replacement comprises one or more amino acids selected from the group consisting of glycine, histidine, isoleucine, methionine, phenylalanine, proline, hydroxyproline, serine, threonine, tryptophan, tyrosine and valine, vitamin(s) consisting of thiamine and/or ascorbic acid, one or more trace metal elements selected from the group consisting of silver, aluminum, barium, cadmium, cobalt, chromium, germanium, manganese, silicon, vanadium, molybdenum, nickel, rubidium, tin and zirconium, one or more halogen elements selected from the group consisting of bromine, iodine and fluorine, as well as one or more ingredients selected from the group consisting of albumin, reduced glutathione, transferrin, insulin and sodium selenite.

8. The method according to claim 1, wherein the pluripotent stem cells are cultured in a system containing laminin-5 and (an) additional extracellular matrix protein(s).

9. The method according to claim 8, wherein the additional extracellular matrix protein is collagen.

10. The method according to claim 1, wherein the pluripotent stem cells are cultured in a laminin-5-treated culture vessel.

11. The method according to claim 10, wherein the laminin-5 is human laminin-5.

12. The method according to claim 1, wherein the pluripotent stem cells do not differentiate during culture.

13. Use of laminin-5 as a cell-supporting material for proliferation of pluripotent stem cells.

14. A culture kit for pluripotent stem cells, which comprises a laminin-5-treated culture vessel and a serum replacement.